| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
104,385 |
96,390 |
$5.11M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
22,730 |
22,160 |
$1.74M |
| 99215 |
Prolong outpt/office vis |
22,493 |
21,446 |
$1.69M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
19,620 |
18,850 |
$1.47M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,435 |
17,134 |
$1.43M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
107,569 |
41,608 |
$1.13M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
10,017 |
9,789 |
$881K |
| 87428 |
|
14,183 |
13,743 |
$710K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,162 |
4,002 |
$349K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24,309 |
23,323 |
$327K |
| 99381 |
|
3,751 |
3,668 |
$307K |
| 99000 |
|
30,856 |
29,315 |
$296K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,827 |
7,585 |
$280K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,495 |
6,205 |
$263K |
| 99205 |
Prolong outpt/office vis |
2,332 |
2,264 |
$255K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26,037 |
18,572 |
$206K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,049 |
2,902 |
$150K |
| 90461 |
|
28,293 |
23,640 |
$144K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,413 |
4,019 |
$112K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,946 |
2,845 |
$86K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
828 |
799 |
$66K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,967 |
5,594 |
$55K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,560 |
4,438 |
$50K |
| 87807 |
|
4,458 |
4,197 |
$47K |
| 69210 |
|
1,251 |
738 |
$38K |
| 99383 |
|
378 |
374 |
$34K |
| 99429 |
|
1,017 |
951 |
$31K |
| 17250 |
|
454 |
425 |
$29K |
| 96160 |
|
12,176 |
11,837 |
$26K |
| 94760 |
|
25,374 |
22,851 |
$22K |
| 92551 |
|
36,596 |
35,675 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,812 |
1,031 |
$17K |
| 99072 |
|
30,044 |
26,792 |
$16K |
| 99050 |
|
1,189 |
1,111 |
$16K |
| 92587 |
|
1,550 |
1,453 |
$15K |
| 97169 |
|
1,054 |
951 |
$13K |
| 92567 |
|
994 |
929 |
$11K |
| 99384 |
|
94 |
93 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
164 |
154 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
631 |
575 |
$8K |
| 99382 |
|
82 |
80 |
$7K |
| 81002 |
|
2,455 |
2,342 |
$7K |
| 69209 |
|
390 |
239 |
$3K |
| 90677 |
|
3,922 |
3,829 |
$1K |
| 96380 |
|
26 |
26 |
$480.08 |
| 86580 |
|
27 |
26 |
$203.91 |
| 99051 |
|
12 |
12 |
$162.24 |
| 90619 |
|
1,465 |
1,415 |
$161.62 |
| 90661 |
|
1,323 |
1,292 |
$54.85 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
283 |
245 |
$29.49 |
| 90674 |
|
2,119 |
2,107 |
$20.12 |
| 99173 |
|
15,448 |
14,825 |
$14.53 |
| 90697 |
|
7,881 |
7,528 |
$11.57 |
| 36416 |
|
1,339 |
1,263 |
$7.35 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
76 |
70 |
$4.56 |
| 90686 |
|
7,611 |
7,388 |
$3.76 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
1,190 |
1,130 |
$2.55 |
| 90651 |
|
4,130 |
4,026 |
$0.69 |
| 97802 |
|
360 |
352 |
$0.58 |
| 90620 |
|
749 |
724 |
$0.21 |
| 90734 |
|
1,635 |
1,590 |
$0.06 |
| 90670 |
|
12,689 |
12,169 |
$0.02 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
31 |
31 |
$0.01 |
| 90633 |
|
8,461 |
8,212 |
$0.00 |
| 90707 |
|
7,716 |
7,469 |
$0.00 |
| 90715 |
|
1,146 |
1,110 |
$0.00 |
| 90700 |
|
1,945 |
1,884 |
$0.00 |
| 1033F |
|
3,238 |
2,596 |
$0.00 |
| 99177 |
|
22,297 |
21,528 |
$0.00 |
| 90681 |
|
2,075 |
2,040 |
$0.00 |
| 94664 |
|
268 |
233 |
$0.00 |
| 1159F |
|
21 |
20 |
$0.00 |
| 90647 |
|
5,772 |
5,606 |
$0.00 |
| 90716 |
|
7,918 |
7,653 |
$0.00 |
| 90680 |
|
7,628 |
7,272 |
$0.00 |
| 90723 |
|
4,886 |
4,745 |
$0.00 |
| 90696 |
|
2,025 |
1,961 |
$0.00 |
| 96161 |
|
31 |
31 |
$0.00 |
| 3008F |
|
21 |
20 |
$0.00 |
| 90381 |
|
12 |
12 |
$0.00 |
| 1125F |
|
21 |
20 |
$0.00 |